sglt2 vs glp 1 Blood Pressure-Lowering Effects of Inhibitors and GLP-1 Receptor Agonists https://link.springer.com/article/10.1007/s11906-025-01342-7 Hypoglycemia Risk With SGLT2 Inhibitors

The researchers winnowed down the Reddit posts to more than 33,600 from nearly 14,600 unique users

Why Injectable GLP-1 Remains the Gold Standard Injectable GLP-1 medications bypass the digestive system entirely, delivering the active compound directly into subcutaneous tissue where it reaches therapeutic concentrations reliably

A comprehensive medical history is essential to identify contraindications, including personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, as GLP-1 agonists carry a boxed warning regarding thyroid C-cell tumors observed in rodent studies

In other words, Protandim seems like a total dumpster fire

This approach is highly relevant to the Ozempic situation, where the goal would be to optimize the health outcomes of diabetic patients amidst supply constraints

doi: 10.1016/S0140-6736(14)60976-4 [DOI] [PubMed] [Google Scholar] 92.Sorli C, Harashima SI, Tsoukas GM, et al